Cross Country Healthcare (NASDAQ:CCRN) Sees Large Volume Increase Following Analyst Upgrade

Cross Country Healthcare, Inc. (NASDAQ:CCRN) saw unusually-strong trading volume on Thursday after Truist Financial raised their price target on the stock from $15.00 to $18.61. Truist Financial currently has a hold rating on the stock. Approximately 528,879 shares traded hands during mid-day trading, a decline of 8% from the previous session’s volume of 572,105 shares.The stock last traded at $18.12 and had previously closed at $18.16.

Several other equities analysts have also issued reports on CCRN. Benchmark lowered their price target on Cross Country Healthcare from $19.00 to $18.00 and set a “buy” rating for the company in a research report on Thursday, November 7th. Barrington Research lowered their price target on Cross Country Healthcare from $21.00 to $19.00 and set an “outperform” rating for the company in a research report on Thursday, August 8th. Three research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $18.54.

Institutional Investors Weigh In On Cross Country Healthcare

A number of large investors have recently made changes to their positions in the company. SummerHaven Investment Management LLC raised its holdings in shares of Cross Country Healthcare by 3.8% during the 2nd quarter. SummerHaven Investment Management LLC now owns 28,376 shares of the business services provider’s stock worth $393,000 after acquiring an additional 1,032 shares in the last quarter. Raymond James & Associates raised its holdings in shares of Cross Country Healthcare by 0.7% during the 2nd quarter. Raymond James & Associates now owns 165,324 shares of the business services provider’s stock worth $2,288,000 after acquiring an additional 1,155 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Cross Country Healthcare by 14.0% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,169 shares of the business services provider’s stock worth $137,000 after acquiring an additional 1,250 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of Cross Country Healthcare by 9.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 16,639 shares of the business services provider’s stock worth $312,000 after acquiring an additional 1,450 shares in the last quarter. Finally, Gladius Capital Management LP raised its holdings in shares of Cross Country Healthcare by 83.4% during the 3rd quarter. Gladius Capital Management LP now owns 3,985 shares of the business services provider’s stock worth $54,000 after acquiring an additional 1,812 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors.

Cross Country Healthcare Stock Performance

The company has a fifty day moving average price of $11.96 and a 200-day moving average price of $13.71. The firm has a market capitalization of $595.14 million, a PE ratio of -361.60, a PEG ratio of 2.13 and a beta of 0.61.

About Cross Country Healthcare

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.